logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (i) New outpatient clients, age distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.14.717.521.719.515.211.210.232.441279381
Cocaine0.15.116.923.621.115.79.48.131.8301611830
Stimulants0.917.527.120.714.49.15.74.627.7674047
Hypnotics and sedatives0.57.312.512.212.211.311.432.636.0302994
Hallucinogens1.924.332.321.28.64.83.63.325.36900
Volatile substances30.440.29.27.64.72.94.01.120.14485
Cannabis 4.235.325.315.08.75.43.42.824.154418965
Other substances 1.916.313.111.19.411.610.226.433.418684
Total1.917.820.819.015.010.97.47.228.81386333326
 

Notes

All countries included excluding Lithuania.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-102 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Monday, 09 July 2012